MAP2K7 and melanoma: We also evaluated the activity of BRAFV600 (PLX4720), MEK (Binimetinib), and PI3K (LY294002) inhibitors on the capacities of m50, m59 and m82 mouse melanoma cell lines to form CFU and determined the IC50 of these drugs (Supplementary Fig. 4J-O).